Design Therapeutics to Participate in Multiple Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 13, 2024
CARLSBAD, Calif., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in the following upcoming investor conferences:
Read more at globenewswire.com
